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1. Introduction 
Urinary tract infections (UTIs) have been described as one of the most common serious 
bacterial diseases affecting infants and young children. Approximately 3% of prepubertal 
girls and 1% of prepubertal boys are diagnosed with UTIs (Riccabona 2003; Ma and 
Shortliffe 2004). The clinical severity of acute renal bacterial infection spans continuously 
from an uncomplicated lower urinary tract infection (i.e. cystitis) to frank abscess formation 
(Soulen et al., 1989). Among these UTIs, renal parenchymal infections, including 
uncomplicated acute pyelonephritis (APN), acute lobar nephronia (ALN), and intrarenal 
abscess, are considered to be more serious forms of UTI. 
Acute lobar nephronia (ALN), also known as acute focal bacterial nephritis, is an acute 
localized bacterial renal infection presenting as an inflammatory mass without liquefaction 
(Rosenfield et al., 1979; Zaontz et al., 1985; Kline et al., 1988; Klar et al., 1996, Uehling et al., 
2000). The typical clinical presentations include fever, flank pain, leukocytosis, pyuria and 
bacteriuria, similar to presentations of patients with renal abscess or acute pyelonephritis 
(Zaontz et al., 1985; Soulen et al., 1989). It has previously been indicated as a complicated 
form of acute renal infection, representing the progression of the inflammatory process of 
APN (Nosher et al., 1988). ALN may also represent a relatively early stage of the 
development of renal abscess (Shimizu et al., 2005). The management of these renal 
parenchymal infections differs widely. Most patients with renal abscess require intensive 
medical therapy with or without surgical intervention, whereas treatment of those with 
ALN, like uncomplicated APN, entails only intravenous and oral antibiotics (Zaontz et al., 
1985; Rathore et al., 1991; Klar et al., 1996). Hence it is important to differentiate these renal 
parenchymal infections. In this Chapter, we would like to review the diagnosis scheme, 
treatment modality, bacterial urovirulence factors, host susceptibility gene and the renal scar 
outcome of ALN. 
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2. Effective ultrasonographic predictor for the diagnosis of acute lobar 
nephronia 
Sonographically, ALN generally presents as severe nephromegaly or a poorly defined, 
irregularly margined focal mass with hyper-, iso- or hypoechogenicity, depending on the 
temporal sequence of the lesions and the resolution of the disease (Rathore et al., 1991; Boam 
and Miser, 1995). Although renal ultrasonography (US) has been considered as the best and 
most-effective screening method, various false positive and false negative findings have 
been reported previously (Rosenfield et al., 1979; Soulen et al., 1989). Computed tomography 
(CT), instead, has been currently recognized as the most-sensitive and -specific imaging 
modality for diagnosing ALN (Kline et al., 1988; Soulen et al., 1989; Rathore et al., 1991; Klar 
et al., 1996; Uehling et al., 2000). CT images of the ALN-infected areas typically appear as 
wedge-shaped, poorly defined regions of decreased nephrogenic density after contrast 
medium administration (Figure 2.1) (Kline et al., 1988; Soulen et al., 1989; Rathore et al., 1991; 
Cheng et al., 2004), and mass-like hypodense lesions in the more-severe form (Lee et al., 
1980). CT, however, is costly and requires the sedation of a young patient.  
 
 
      (a)               (b) 
Fig. 2.1. The characteristic non-enhanced (a) and contrast-enhanced (b) CT scans for a 2-
year-old patient with acute lobar nephronia, who presented with severe left nephromegaly 
while without a focal mass sonographically. Note no attenuation area seen in the kidney 
before enhancement (Cheng et al., 2004). 
A new systemic radiologic imaging evaluation scheme, the combination of renal US and CT 
scanning, was proposed to assist ALN diagnosis in pediatric patients. Enlarged kidneys 
and/or focal masses were utilized to be the sonographic preselection features for 
subsequent CT evaluation. CT scan is used when the patient shows (1) a markedly enlarged 
kidney or focal mass on the initial US scan; or (2) poor response to the initial 72 hours 
antibiotic treatment while his/her kidneys appear borderline nephromegaly 
sonographically (Cheng et al., 2004).  
From our results (Cheng et al., 2004), severe nephromegaly (i.e. renal length greater than 
mean +3 SD for age) on at least one side of the kidneys is very sensitive for the diagnosis of 
ALN. A higher sensitivity was achieved when US focal mass findings were included with 
severe nephromegaly as the diagnosing criteria. In terms of the kidneys, focal masses on US 
scans correlated much better with the final ALN diagnosis than other US characteristics 
evaluated. The use of focal mass findings as an effective predictor for ALN was limited since 
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its sensitivity was only 25% despite a specificity of 100%. Severe nephromegaly was a very 
useful sonographic diagnostic criterion for kidneys affected with ALN with a sensitivity of 
90.0%. Sensitivity increased to 95% when severe nephromegaly together with focal mass 
was used as the sonographic predictor. 
In summary, pediatric ALN was effectively predicted using sonographic findings of severe 
nephromegaly and/or focal mass prior to CT scanning. 
3. Effective duration of antimicrobial therapy for the treatment of acute lobar 
nephronia 
Treatment for patients with ALN generally requires intravenous and oral antibiotic 
medication as does treatment for uncomplicated APN (Zaontz et al., 1985; Rathore et al., 
1991; Klar et al., 1996). Surgical intervention is rarely needed for ALN patients, except for 
those with concomitant urological abnormalities which may increase the risks of occurrence 
of acute bacterial infection (Uehling et al., 2000). Although it has been suggested that the 
treatment duration for ALN needs to be at least the same as that for uncomplicated APN, 
recommendations for the duration of antibiotic treatment still remains somewhat 
inconclusive, and to the best of our knowledge, for neither condition, has a rigorous 
therapeutic efficacy comparison of relevant medication been performed (Rathore et al., 
1991). 
We have performed a study sought to determine the appropriate duration of effective 
antibiotic therapy for the management of pediatric ALN patients (Cheng et al., 2006). 
Patients who first presented as febrile UTI and who later were diagnosed with positive CT 
findings of ALN were entered into this study for receiving either a two-week or a three-
week intravenous and oral antibiotic therapeutic program. The demographic data and 
clinical results of these patients were compared. In addition, the identification of any clinical 
or laboratory factors that are likely associated with treatment failure was also attempted.  
These two treatment groups had similar demographic data and clinical results (Table 3.1). 
Most of the patients had been febrile for around three-to-four days, ranging from one day to 
two weeks or so, prior to admission. Once patients had been admitted, all responded well to 
the initial antibiotic treatment regimen and the fever generally subsided within about a 
week. CT scans indicated that 18 patients had left ALN, 12 right ALN, and 11 bilateral ALN 
in the two-week treatment group. Corresponding figures for the three-week treatment 
group were 16, 12 and 11 patients respectively. The distribution of these ALN diagnoses was 
quite similar between the two treatment groups.  
Among the 80 patients participating in this study, Escherichia coli was the most-common 
pathogen cultured from the patient urine samples (59/61) such a finding being consistent 
with the results of previous studies (Kline et al., 1988; Nosher et al., 1988; Rathore et al., 1991; 
Boam and Miser, 1995; Uehling et al., 2000). Interestingly, the proportion (percentage) of 
Escherichia coli cultured in cases of ALN appears to be much greater than the corresponding 
figure reported for first-time UTIs (Hoberman and Wald, 1999). 
Sixty-nine ALN patients, 40 from the two-week treatment group and 29 from the three-week 
treatment group, underwent VCUG evaluation. Sixteen patients in the two-week treatment 
group (40%) and eleven in the three-week treatment group (38%) had vesicoureteral reflux 
(VUR). Among the patients with VUR, a grade-III or greater was noted in eight and nine 
patients respectively, treated by the two-week and the three-week antibiotic courses. For 
patients who underwent VCUG, no difference as regards the presence of VUR in either 
frequency or severity was found between the two treatment groups. 
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 Two-week treatment 
group (n=41) 
Three-week treatment 
group (n=39) 
P 
Age, years 3.72  4.14 4.16  4.22 NS 
   Range 4 mo – 16 yr 4 mo - 14yr 8mo  
Girls 24 (58.5%) 23 (59.0%) NS 
Fever duration prior to 
admission, days 
3.90  3.06 3.97  2.72 NS 
   Range, days 1 – 14 1-13  
Fever continuation 
following antibiotic 
treatment, days 
2.73  1.28 3.43  2.05 NS 
   Range, days 1 – 7 1 – 8  
White blood cell count, 
(cells/L) 19,107  8,772 19,600  10,212 NS 
   Leukocytosis (>15,000 
WBC/L) 28 (68.3%) 25 (64.1%) NS 
C-reactive protein, 
(mg/L; normal <5) 
137.7  98.1 119.3  74.0 NS 
Urine culture    
   Escherichia coli 31 (75.6%) 28 (71.8%) NS 
      E. coli > 105cfu/mL 25 (61.0%) 25 (64.1%) NS 
   Klebsiella pneumoniae 1 (2.4%) --- --- 
   Pseudomonas aeruginosa --- 1 (2.6%) --- 
   No isolatable organism 9 (22.0%) 10 (25.6%) NS 
Blood culture    
   Escherichia coli 1 (2.4%) 2 (5.1%) --- 
   Staphylococcus aureus --- 1 (2.6%) --- 
   No isolatable organism 40 (97.6%) 36 (92.3%) NS 
Treatment failure 7 (17.1%) 0 (0%) 0.01 
NS indicates not significant 
Table 3.1. Clinical and laboratory data for 80 children with ALN enrolled for different 
treatment protocol (Cheng et al., 2006). 
None of our patients revealed any evidence of underlying diseases such as diabetes mellitus, 
immunodeficiency, nor did any feature structural abnormality of the urinary-tract system 
such as neurogenic bladder, or upper or lower urinary-tract obstruction apart from VUR. 
Reflux was noted in about 40% of the ALN children in this study, a figure quite comparable 
to that in several previous studies (Kline et al., 1988; Klar et al., 1996; Uehling et al., 2000). 
This frequency of VUR among patients with ALN is close to that in children with UTI (Ilyas 
et al., 2002), thus, VUR may not be a necessary prerequisite for the development of ALN. 
Overall, seven treatment failures were noted in this study (8.8%; 95% CI, 2.6%-14.9%), all of 
which had been managed by a two-week antibiotic course (17.1%; 95% CI, 5.6%-28.6%). 
Statistical significance was noted in regard to treatment success rate between these two 
groups (p=0.01). Among these patients with treatment failure, one demonstrated persistent 
infection during the treatment course, and six others were considered to be relapse by 
revealing a positive Escherichia coli urine culture with the same antibiotic sensitivity profile 
as had been the case previously. 
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Table 3.2 lists the clinical characteristics of these seven patients as compared with those 
successfully treated with the two-week antibiotic course. Proportionally more girls may be 
noted in the failures group than the non-failures group, but the difference was not 
statistically significant (p=0.21). The patients failing the two-week antibiotic treatment 
presented with a more-pronounced fever duration prior to admission (6.00  5.54 vs. 3.47  
2.16 days; p=0.04), and they were more likely to be Escherichia coli infection positive [>105 
cfu/mL; 100% (7/7) vs. 52.9% (18/34); p=0.03]. The distribution of ALN foci, VCUG 
characteristics, and other clinical results revealed no difference between the failures and 
non-failures groups.  
For the treatment-failure patients, the antibiotic treatment course was extended/restarted 
for an additional ten days. Subsequent urine culture and clinical-symptom evaluation at the 
follow-up exams revealed eventual successful treatment. 
 
 
Failures with two-week 
treatment protocol (n=7) 
Non-failures with two-week 
treatment protocol (n=34) 
Age, years 4.07  4.31 3.65  4.16 
   Range 4 mo – 9 yr 4 mo – 16 yr 
Girls 6 (85.7%) 18 (52.9%) 
Fever duration prior to 
admission, days† 
6.00  5.54 3.47  2.16 
   Range, days 1 – 14 1-10 
Fever continuation following 
antibiotic treatment, days 
2.14  1.21 2.85  1.28 
   Range, days 1 – 4 1-7 
White blood cell count, 
(cells/L) 22,257  8,656 18,459  8,781 
   Leukocytosis (>15,000 
WBC/L) 6 (85.7%) 22 (64.7%) 
C-reactive protein, (mg/L; 
normal <5) 
107.3  113.3 143.4  95.9 
Escherichia coli in urine culture 7 (100%) 24 (70.6%) 
   E. coli > 105cfu/mL‡ 7 (100%) 18 (52.9%) 
†: p=0.04; ‡: p=0.03 
Table 3.2. Comparison of demographic data, clinical characteristics and laboratory results 
between the ALN patients with treatment failure and those with treatment success for the 
two-week antibiotic therapy protocol (Cheng et al., 2006). 
From our results, all ALN patients with the three-week antibiotic course were successfully 
treated, whereas seven treatment failures (17.1% of treated patients) were noted in the two-
week treatment group. This observation suggests that the two-week antibiotic treatment, 
usually scheduled for APN, may not be appropriate for the treatment of ALN. Patients who 
failed the two-week treatment modality were more likely to have prolonged fever prior to 
admission and to reveal positive Escherichia coli infection (>105 cfu/mL). The longer febrile 
history prior to admission may suggest that these patients may be prone to develop a more 
severe disease state than their counterparts, and that, by necessity, a longer antibiotic 
treatment course will be needed for such individuals. Indeed, these treatment failures were 
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all successfully dealt with by an additional ten-day antimicrobial therapy regimen. Whether 
host factors, or the virulence of Escherichia coli, relates to ALN and plays a role leading to 
treatment failure remains an issue that should be clarified. 
4. A high incidence of renal scarring is associated with child with acute lobar 
nephronia 
The pathogenesis of renal scarring after a febrile UTI remains unclear. Some risk factors 
making children with a UTI more vulnerable to renal damage include young age at the time 
of infection (Winberg et al. 1982), delayed treatment (Miller and Phillips 1981; Winberg et al. 
1982), the presence of vesicoureteral reflux (VUR) (Biggi et al. 2001; Chroustova et al. 2006; 
Faust et al. 2009), and although mentioned infrequently, the extent of kidney lesions (Biggi et 
al. 2001). ALN is a severe disease entity, with extensive renal parenchymal involvement 
(Cheng et al. 2009). Thus, we performed a prospective study to evaluate renal scar formation 
after ALN as compared with APN. In this prospective study (Cheng et al. 2010a), we also 
examined nearly all the previously proposed risk factors for renal scarring.  
DMSA scintigraphy is a sensitive diagnostic method for renal scarring but does not always 
distinguish between new and old lesions, or differentiate renal dysplasia from acquired 
post-infection scars. It is possible that we might have overestimated the occurrence of renal 
scars that were related to the index infection. Thus, the exclusion of children with history of 
prior UTI or the development of recurrent UTI before DMSA scintigraphy in current study 
was designed to keep any overestimation of renal scarring to a minimum. 
In this investigation, a total of 218 children with a first documented febrile UTI (109 APN, 
109 ALN) who fulfilled our patient selection criteria and completed the final DMSA 
scintigraphy were analyzed. Patient characteristics were comparable between the two ALN 
treatment groups (Table 4.1). The frequency of renal scarring at scintigraphy was similar 
between the 2-week and 3-week successful treatment groups. The demographic and clinical 
data for the APN (all had received 10-day treatment) and ALN patients are shown in Table 
4.2. Acute lobar nephronia was a more severe disease than APN, as judged by higher 
inflammatory indices and longer fever duration after and/or before treatment. The 
incidence of renal scarring was much higher in ALN than in APN patients. 
Regression analysis of the 218 patients with a first febrile UTI showed that renal scarring 
was more likely to occur in children with higher inflammatory indices (white blood count: 
198027652 vs. 15478 6853; and C-reactive protein: 124.689.8 vs. 68.469.6; P < 0.001), 
longer duration of fever after (P < 0.001) and/or before treatment (P = 0.001), and the 
presence of VUR (P = 0.044). However no relationship was found between renal scarring 
and age at diagnosis or gender.  
Higher inflammatory indices and longer fever duration after and/or before treatment were 
strongly correlated with ALN (Table 4.2), these factors, henceforth, were determined not to 
be independent predictor variables in a multiple logistic regression analysis on renal 
scarring. ALN was shown to be the only independent risk factor for renal scarring (P < 
0.001; Table 4.3) 
The duration and route of administration of antibiotics have been shown not to influence the 
risk for renal scarring in patients with APN (Hoberman and Wald et al. 1999; Bouissou et al. 
2008). Our previous prospective study (Cheng et al. 2006) suggested that 3 weeks of 
antibiotic therapy was the treatment of choice for all radiographically documented ALN 
patients; a longer duration of antibiotic use resulted in the successful treatment for ALN but 
did not reduce the risk for renal scarring. In most reported studies, including ours, the 
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outcome in terms of renal scarring seems to be unrelated to the mode and duration of 
antibiotic treatment. 
 
Parameter 
2-wk Treatment  
ALN Group 
3-wk Treatment 
ALN Group 
P 
Patient number 54 55  
Male/Female 25/29 24/31 NS 
Age (years) 
2.62 ± 3.08 
Median: 1.00 
Range: (0.25, 15.00) 
3.17 ± 3.01  
Median: 1.33 
Range: (0.07, 9.42) 
NS 
WBC count, cells/μl 21144 ± 7205 22014 ± 9608 NS 
C-reactive protein, mg/L 156.1 ± 94.4 150.0 ± 85.1 NS 
Vesicoureteral reflux 48.1% (25/52) 35.9% (19/53) NS 
E. coli percentage in urine culturea 95.1% (39/41) 85.7% (36/42) NS 
Fever duration before treatment, 
days 
3.54 ± 2.23 4.07 ± 3.37 NS 
Fever duration after treatment, 
days 
3.19 ± 1.76 4.02 ± 2.81 NS 
Time from ALN to DMSA renal 
scan, years 
1.27 ± 1.02 1.40 ± 1.18 NS 
Renal scar formation 88.9% (48/54) 89.1% (49/55) NS 
WBC, white blood cell; DMSA, dimercaptosuccinic acid; NS, not significant. a excluding urine cultures 
showing no growth. 
Table 4.1. Demographic and clinical data for 109 patients with ALN (Cheng et al. 2010a). 
 
Parameter APN ALN P 
Patient number 109 109  
Male/Female 49/60 49/60 NS 
Age (years) 
2.80 ± 3.59  
Median: 1.00 
Range: (0.16, 15.00) 
2.90 ± 3.04 
Median: 1.16 
Range: (0.07, 15.00) 
NS 
WBC count, cells/μl 14729 ± 4656 21583 ± 8475 < 0.001 
C-reactive protein, mg/L 53.4 ± 46.5 153.0 ± 89.5 < 0.001 
Vesicoureteral reflux 34.6% (36/104) 41.9% (44/105) NS 
E. coli percentage in urine culturea 78.8% (82/104) 90.4% (75/83) 0.033 
Fever duration before treatment, 
days 
1.90 ± 1.62 3.81 ± 2.86 < 0.001 
Fever duration after treatment, 
days 
1.02 ± 0.75 3.61 ± 2.37 < 0.001 
Time from APN or ALN to DMSA 
renal scan, years 
1.21 ± 1.06 1.34 ± 1.10 NS 
Renal scar formation 34.9% (38/109) 89.0% (97/109) < 0.001 
a excluding urine cultures showing no growth. 
Table 4.2. Demographic and clinical data for patients with APN and patients with ALN 
(Cheng et al. 2010a). 
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Variable aOR 
95% CI 
P 
Lower Upper 
Disease 
APN 
ALN 
 
1.00 
13.56 
 
-- 
6.53 
 
-- 
28.19 
 
-- 
< 0.001 
Gender 
Male 
Female 
 
1.00 
0.95 
 
-- 
0.47 
 
-- 
1.93 
 
-- 
NS 
Age 
< 1 year 
1-5 years 
> 5 years 
 
1.00 
0.85 
0.91 
 
-- 
0.39 
0.35 
 
-- 
1.86 
2.33 
 
-- 
NS 
NS 
Vesicoureteral reflux (VUR) 
No VUR 
VUR 
 
1.00 
1.83 
 
-- 
0.90 
 
-- 
3.74 
 
-- 
0.096 
Table 4.3. Multiple logistic regression analysis for scar formation (Cheng et al. 2010a). 
The severity of APN as evaluated by the extent of renal lesions on acute DMSA scanning has 
been suggested to be a predictor for renal scarring (Biggi et al. 2001; Chiou et al. 2001). Our 
data on higher renal scar odds ratio in ALN, a more severe form of acute renal infection than 
APN, as well as in higher inflammatory indices and longer fever duration after and/or 
before treatment strongly support this suggestion.  
The role of VUR in the development of renal scars remains controversial (Hoberman and 
Wald et al. 1999; Gordon et al. 2003; Hoberman et al. 2003; Moorthy et al. 2005). Some recent 
prospective studies (Hoberman et al. 2003; Chroustova et al. 2006; Polito et al. 2006; Bouissou 
et al. 2008) and a cross-sectional meta-analysis (Faust et al. 2009) have shown a significant 
association between the presence of VUR and the risk for renal scarring. However, the 
presence of VUR was a weak predictor of renal scarring in the present study. The additional 
effect of VUR above that achieved by including only the presence of ALN (nephromegaly 
and/or severity of infection) in the multiple logistic regression model was not statistically 
significant for predicting renal scarring. 
In conclusion, our results showed a new finding that ALN is associated with a very high 
incidence of renal scarring, in comparison to APN, irrespective of the duration of antibiotic 
treatment. 
5. Comparison of urovirulence factors and genotypes for bacteria causing 
acute lobar nephronia and acute pyelonephritis 
Escherichia coli is the most common cause of various UTIs, including cystitis, prostatitis and 
pyelonephritis (Johnson and Kuskowski et al. 2005). Our early studies showed that E. coli 
was the most common pathogen cultured from the patients with ALN (Cheng et al. 2004, 
2006), having a higher percentage of pathogens than the first-time UTIs (Hoberman and 
Wald 1999). This finding has led us to this investigation of the pathogenetic association of 
the bacterial virulence factors as well as the genotypes of the E. coli isolates in pediatric 
ALN. 
Henceforth, we have sought to determine the role of E. coli urovirulence factors in the 
development of ALN as compared to APN in pediatric patients who have no underlying 
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diseases or urinary anatomical anomalies except vesicoureteral reflux (VUR) (Cheng et al., 
2007). Through our previous published systematic diagnostic scheme (Cheng et al. 2004, 
2006), patients who first presented as febrile UTIs and later were diagnosed with positive 
CT findings of ALN or positive technetium 99m-dimercaptosuccinic acid scintigraphic 
(99mTc-DMSA) findings of APN were enrolled into this study. 
Patients were included for study only if E. coli was the sole isolate recovered from their 
urine specimens. Single colonies of the E. coli were randomly selected from the initial culture 
plate and stored in 20% glycerol at –70C until used. Urovirulent factors examined included 
genes associated with various fimbrial and nonfimbrial adhesins (papG I, papG II, papG III, 
fimH, sfa, foc, afa), aerobactin receptor (iutA), hemolysin (hlyA), and cytotoxic necrotizing 
factor I (cnf1) (Tseng et al. 2001, 2002; Johnson 2003; Johnson and Russo 2005). The difference 
in the prevalence of various E. coli urovirulent factors for the pediatric patients with ALN or 
APN was statistically analyzed. In addition, genotyping of these E. coli isolates was also 
performed to examine the possible clonal differences.  
A total of 88 patients who fulfilled enrollment criteria were included for study. Among 
these, 46 patients were diagnosed with ALN and 42 cases with APN. Seventy-two patients, 
42 from the ALN group and 30 from the APN group, underwent VCUG evaluation. 
Seventeen (40.5%) patients in the ALN group and 12 (40%) in the APN group had VUR. 
Among the patients with VUR, grade-IV reflux or greater was noted in 3 patients each with 
APN and ALN. Among patients who underwent VCUG, no difference in the presence of 
VUR in either frequency or severity was found between the two disease categories. 
Among the 88 E. coli clinical isolates, papG adhesin genes (including classes I to III) were 
detected in 44 of the ALN isolates and 32 of the APN ones (95.7% vs. 76.2%, p<0.05). The 
class II allele was more commonly noted in the group of ALN (95.7% vs. 73.9%, p<0.05; 
Table 5.1) (Cheng et al., 2007). In contrast, no significant difference was found for the class III 
allele between the two groups. None of the isolates had the class I allele. In addition, papG II 
allele was noted in all ALN patients with normal VCUGs (25/25) while only in 16 of the 18 
APN patients with normal VCUGs. The genetic determinant for type 1 fimbriae, fimH, was 
the most common virulence factor (95.5%) found among the isolates; however, no 
statistically significant difference between the two groups was noted. Similarly, the 
remaining genetic determinants for other virulence factors did not reveal any significant 
difference between the two groups. Multivariate logistic regression analysis revealed that 
papG II allele was significantly associated with ALN (p<0.005; odds ratio, 17.16, 95% CI: 
2.76-106.70). This association was independent of the presence of VUR. 
To cause bacterial infections of the upper urinary tract, the microorganisms need to reach 
the kidney through ascending or hematogenous routes. Bacterial adherence to the 
uroepithelial cells by fimbrial or nonfimbrial adhesins is considered to be an important 
factor in the development of upper urinary tract infection via the ascending route (Tseng et 
al. 2001). Among these adhesins, papG variants, which are located at the tip of P-fimbriae 
and bind preferentially to different Gal ( 1-4) Gal-containing glycolipids in the human 
epithelium of proximal and distal tubules and in collecting ducts, have been implicated to 
be associated with the severity of renal infection (Källenius et al. 1981; Johnson 1991; Wang et 
al. 2002; Johnson and Russo 2005). Previous studies have shown that the papG II allele is 
associated with acute pyelonephritis (APN) (Johanson et al. 1993; Otto et al. 1993; Jantunen et 
al. 2000), while the papG III allele predominates in less severe genitourinary infections, such 
as acute cystitis and prostatitis (Johanson et al. 1993; Johnson et al. 1998; Ruiz et al. 2002). 
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Virulence factor 
ALN group 
(n=46) 
APN group 
(n=42) 
P 
papG (P-fimbriae)    
   Class I 0 (0%) 0 (0%) --- 
   Class II 44 (95.7%) 31 (73.8%) 0.01 
   Class III 5 (10.9%) 4 (9.5%) NS 
fimH (type 1 fimbriae) 44 (95.7%) 40 (95.2%) NS 
sfa (S-fimbriae) 7 (15.2%) 4 (9.5%) NS 
foc (F1C-fimbriae) 5 (10.9%) 8 (19.1%) NS 
afa (afimbrial adhesins) 3 (6.5%) 4 (9.5%) NS 
iutA (aerobactin receptor) 35 (76.1%) 32 (76.2%) NS 
hlyA (hemolysin) 21 (45.7%) 23 (54.8%) NS 
Cnf1 (cytotoxic necrotizing factor 1) 8 (17.4%) 14 (33.3%) NS 
NS indicates not significant  
Table 5.1. Comparison of virulence factors of Escherichia coli isolated from patients with ALN 
and APN (Cheng et al., 2007). 
Results in this study (Cheng et al. 2007) also indicated that papG II was significantly more 
prevalent in pediatric patients with ALN than those with APN. This finding provides 
further evidence that the papG II allele might play a more important pathogenic role than 
other adhesins in the development of severe renal infectious diseases. In addition, this 
finding may offer an insight for the future development of vaccine against such severe renal 
parenchymal inflammatory diseases. 
The fimH gene sequence which encodes the type I fimbriae was present uniformly in most of 
the isolates from either ALN or APN patients. This is in accordance with the fact that type I 
fimbriae is present in nearly all E. coli isolates from patients with various UTIs, ranging from 
cystitis, prostatitis to APN (Johnson and Stell 2000; Johnson and Russo 2005). This study 
further extends the proposed mechanism that fimH gene (i.e. type I fimbriae) was generally 
required for renal bacterial infection disease to be occurred, no matter what degree of 
severity it is. In contrast, other fimbrial and nonfimbrial adhesins (i.e. sfa, foc, and afa genes) 
were rarely detected among our isolates and their pathogenic roles in ALN and APN are 
likely of less importance, a finding similar to those reported previously in the less severe 
renal infection categories (Siitonen et al. 1993; Blanco et al. 1997; Mitsumori et al. 1998). 
Host compromise can decrease the requirements for bacterial virulence in causing severe 
urinary tract infections, and, henceforth, change the distribution of papG pathogenetic 
determinants among the clinical isolates studied (Jantunen et al. 2000; Tseng et al. 2001, 2002; 
Johnson and Russo 2005). In this study, the lack of influence of VUR, the only host 
compromising factor revealed, on the determination of urovirulence factors could be due to 
the similar distribution and severity of VUR between these two groups. Such similarities in 
VUR severity distribution and occurrence frequency were also reported in our earlier 
studies and many others (Kline et al. 1988; Sargent and Stringer 1995; Uehling et al. 2000; 
Cheng et al. 2004, 2006). In addition, this frequency of VUR among patients with ALN or 
APN (~ 40%) is close to that in children with UTI (Ilyas et al. 2002). Thus, VUR may not be a 
necessary prerequisite (i.e. significant predisposing host factor) for the development of 
ALN. 
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Fig. 5.1. PFGE pattern of representative XbaI-digested genomic DNA from Escherichia coli 
isolates. Lane M, lambda DNA concatemer standard; lanes 1-5, 7, and 8, clinical isolates in 
the APN group; lanes 6, 9-13, clinical isolates in the ALN patients. (Cheng et al., 2007). 
A total of 85 genotypes were found among the 88 E. coli isolates. Some representative 
banding patterns are shown in Figure 5.1 (Cheng et al., 2007). These isolates from both ALN 
and APN patients demonstrated a variety of genotypes. A total of 85 genotypes contained 
multiple isolates, and 2 genotypes contained isolates from both ALN and APN groups, 
suggesting that isolates of the same clone could be associated with either entity. 
In summary, PFGE analysis indicated that no major genotype was associated with the 
disease category among these 88 clinical E. coli isolates. As to the urovirulence factors 
examined, the papG class II gene was the most strongly associated pathogenic determinant 
for the pediatric ALN patients who have no underlying diseases except VUR. Furthermore, 
even without VUR, patients can still develop clinical symptoms and radiographic 
characteristics associated with ALN in the presence of papG II gene. 
6. Comparison of bacterial urovirulence genotypes among patients with 
urosepsis, acute pyelonephritis, and acute lobar nephronia 
Complex pathogen–host interactions determine the patient’s susceptibility to bacterial 
infections (Rushton 1997; Ma and Shortliffe 2004). Various virulence factors have been 
identified that enhance E. coli uropathogenicity, including the facilitation of colonization and 
invasion of the host, avoidance or disruption of host defense mechanisms, injury to host 
tissue, and/or stimulation of a noxious host inflammatory responses (Rushton 1997; 
Johnson and Stell 2000). Furthermore, some virulence factors are more prevalent in specific 
urinary tract infectious diseases, thus offering insights into future vaccine development 
(Jantunen et al. 2000; Ruiz et al. 2002; Tseng et al. 2002). 
We sought to further elucidate the roles of E. coli virulence factors in the development of 
urosepsis and two other severe renal parenchymal infectious diseases, APN and ALN, in 
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pediatric patients who show no host-compromising factors, except for vesicoureteral reflux 
(VUR) (Cheng et al., 2010b). Twenty-five virulence factors were analyzed, including genes 
associated with fimbrial and nonfimbrial adhesins (papAH, papC, papEF, papG I, papG II, 
papG III, sfaS, focG, afa, bmaE, gafD, nfaE, fimH), toxins (hlyA, cnf1, cdtB), siderophores (fyuA, 
iutA), capsule synthesis (kpsMT II, kpsMT III), invasion of brain endothelium (ibeA), serum-
resistance (traT), markers for virulence-associated E. coli serogroup O4 (rfc) and colcin V 
plasmids (cvaC), and the coding region of PAI from the uropathogenic strain CFT073 (PAI) 
(Johnson and Stell 2000; Jantunen et al. 2000; Tseng et al. 2002; Johnson and Kuskowski et al. 
2005; Cheng et al. 2007). Moreover, the prevalence rates of these 25 urovirulence genes for 
patients with the three invasive UTIs (i.e. APN, ALN, and urosepsis) will also be compared 
with those for patients diagnosed as cystitis. 
The inclusion criteria and diagnostic scheme for patients with documented episodes of ALN 
or APN were the same as those stated in our earlier publication (Cheng et al. 2007). 
Urosepsis was defined as a patient with bacteremia arising from a urinary tract source 
(Johnson et al. 1988). Cystitis was defined as afebrile pediatric patients with just only 
localizing symptoms such as dysuria, frequency, urgency, cloudy urine or lower abdominal 
discomfort. Exclusion criteria included any evidence of underlying diseases such as diabetes 
or immunodeficiency, or any structural anomalies such as neurogenic bladder, posterior 
urethral valve, urinary diversion, bladder diverticulum, ureterocele, and urinary tract 
obstruction apart from VUR. 
Among the 123 E. coli isolates from APN, ALN and urosepsis, the overall prevalence rate of 
various virulence factors ranged from 2% (nfaE, nonfimbrial adhesin-1) to 97% (fimH, Type I 
fimbriae). In addition, all but one APN clinical isolate presented at least one adhesin. Of the 
25 virulence factors examined, 17 showed a statistically significant distribution among these 
three invasive UTI categories (Table 6.1). ALN isolates differed significantly from other 
invasive UTI isolates (i.e. APN and urosepsis) due to their lower prevalence of cdtB and a 
medium prevalence of cvaC. Moreover, ALN isolates showed a higher prevalence of papAH, 
papC, papEF, and papG II, compared with APN isolates, and a lower prevalence of papG I, 
focG, afa, bmaE, hlyA, cnf1, iutA, kpsMT III, rfc, and traT compared with urosepsis isolates. 
APN isolates were significantly different from other two types of invasive isolates due to a 
lower prevalence of cvaC. Additionally, APN isolates had a lower prevalence of papG I, focG, 
afa, bmaE, iutA, kpsMT III, rfc, traT, and PAI compared with urosepsis isolates. Finally, 
urosepsis isolates significantly differed from all other two types of invasive UTI isolates due 
to a higher prevalence of papG I, focG, afa, bmaE, iutA, kpsMT III, rfc, cvaC, and traT  
(Table 6.1). 
In contrast, among the 24 clinical isolates from cystitis, eight virulence genes were not noted, 
and in which, six were bacterial adhesins (i.e. papG I, sfaS, afa, bmaE, gafD, nfaE). However, 
the highest prevalence rate (100%) was noted in fimH adhesin, the virulence gene sequence 
encoding type I fimbriae. As compared to the combination of three invasive UTI diseases 
(i.e. APN, ALN and urosepsis), the cystitis isolates had a lower prevalence of papAH, papC, 
papEF, papG II, sfaS, afa, bmaE, hlyA, cdtB, fyuA and ibeA (Table 6.1). 
In this investigation, none of the patients presented with any evidence of underlying disease 
or structural anomalies except VUR, and a similar distribution of severity and frequency of 
occurrence of VUR was noted among the three different invasive UTI disease groups; APN, 
ALN, and, urosepsis. Hence, distinct syndrome-specific differences in distribution for 
certain virulence factors, but conservation across syndromes for others, is likely related to 
differences in bacterial urovirulence and uropathogenicity among these three invasive 
bacterial urinary infectious diseases. 
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Table 6.1. Comparison between virulence factors among 147 Escherichia coli isolates from 
patients with cystitis, acute pyelonephritis (APN), acute lobar nephronia (ALN), or 
urosepsis. (Cheng et al., 2010b). 
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The fimH, the gene sequence that encodes type I fimbriae, was found in nearly all strains 
(97%) from these three invasive UTI diseases and did not vary statistically among these 
three syndromes. This finding further extends the proposed mechanism, namely, that the 
fimH gene is generally required for renal bacterial infectious disease to occur, regardless of 
level (Johnson and Stell 2000; Tseng et al. 2002; Johnson and Russo 2005; Moreno et al. 2005; 
Cheng et al. 2007).  
An aggregate virulence factor score for each isolate was calculated as the number of unique 
virulence factors detected, with adjustment for multiple detection of pap (P-fimbriae) and 
sfa/foc (S/F1C fimbriae) (Johnson and Kuskowski et al. 2005). The median scores were 6.5 
(range: 1-12), 9 (range: 2–12), 9 (range: 6–13), and 14 (range: 9–17) for cystitis, APN, ALN, 
and urosepsis isolates, respectively. A Kruskal-Wallis nonparametric one way ANOVA 
analysis indicated the aggregate virulence factor score was significantly different among 
these four disease groups (p < 0.0001). Post hoc analyses using Dunn method (2-sided) 
between any two disease categories indicated that urosepsis isolates presented significantly 
higher aggregate virulence scores than isolates from any other three diseases (urosepsis vs. 
cystitis, urosepsis vs. APN and urosepsis vs. ALN; p < 0.0001). Isolates from cystitis, rather, 
showed significantly lower aggregate virulence scores than those from any other three 
invasive UTI diseases (cystitis vs. APN and cystitis vs. ALN; p < 0.01; cystitis vs. urosepsis; p 
< 0.0001). However, no significant difference was noted between the APN and ALN isolates 
(p = 0.88).  
In summary, for the three invasive urinary infectious diseases, distinct syndrome-specific 
differences in distribution for certain virulence factors, but conservation across syndromes 
for others is noted. This likely resulted from the differences in bacterial urovirulence and 
uropathogenicity. Our findings also suggested that urosepsis isolates carry more virulence 
factors and are therefore likely more urovirulent compared with cystitis, APN and ALN 
isolates. 
7. Genetic polymorphisms and susceptibility for pediatric patients with 
parenchymal renal infections 
Despite of aforementioned efforts on correlating urovirulence factors of uropathogenic E. 
coli with the disease severity, the intra-individual differences in clinical presentations are 
still noted among UTI patients. This underlies the importance of host factors, such as 
mechanistic dysfunctions like vesicoureteral reflux (VUR) and genetic variations, in 
patient’s susceptibility to the bacterial invasion and infection (Artifoni et al. 2007; Lundstedt 
and Leijonhufvud et al. 2007; Lundstedt and McCarthy et al. 2007; Hawn, Scholes and Li et al. 
2009; Sivick and Mobley 2010).  
The inflammatory response caused by the attachment/invasion of uropathogenic E. coli into 
the urinary tract is determined by different molecular interactions between the bacteria and 
epithelial cells (Artifoni et al. 2007; Sivick and Mobley 2010). The initial recognition for 
bacterial attachment/invasion occurs through the coordination efforts of various toll-like 
receptors and different Pathogen-Associated Molecular Patterns (PAMPs) such as bacterial 
flagellin and lipopolysaccharide (Hawn, Scholes and Li et al. 2009). Following that, potent 
chemoattractants secreted by the infected epithelial cells will attract inflammatory cells, and 
the chemokine receptors will then direct recruited inflammatory cells’ interactions with 
mucosal barrier. Subsequent steps in the inflammatory process will determine the balance 
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between the health and the disease severity (Godaly et al. 2001; Artifoni et al. 2007). 
Neutrophil-dependent innate host defense system is considered to be an important 
antimicrobial process to maintain the sterility of the urinary tract. It starts from signal 
transmission by cooperative efforts of toll-like receptor 4 (TLR-4) and P fimbriae of 
uropathogenic E. coli, followed by the secretion of main chemoattractant for neutrophils, IL-
8. The IL-8 mediates its effects on neutrophil chemotaxis, transepithelial infiltration into the 
urinary tract, activation and phagocytosis and killing of bacteria through the receptors 
CXCR1 and CXCR2 (Godaly et al. 2001; Lundstedt and Leijonhufvud et al. 2007; Lundstedt 
and McCarthy et al. 2007). 
Henceforth, we sought to determine the correlations in the polymorphisms for genes 
regulating the initial recognition of bacterial invasion (i.e. TLR-4, toll-like receptor 4) and 
subsequent neutrophil infiltration and activation for bacteria clearance (i.e. IL-8, interleukin-
8; and CXCR1, CXCR2; receptors for interleukin-8) among the pediatric UTI patients with 
different clinical severity; namely, acute pyelonephritis (APN) and the clinically more severe 
UTI disease, acute lobar nephronia (ALN) (Cheng et al., 2011a). In addition, since VUR is a 
well-known risk factor for severe parenchymal infectious disease as APN (Orellana et al. 
2004; Artifoni et al. 2007), a subgroup of APN and ALN patients without VUR will also be 
examined to exclude the possible effects caused by VUR. 
Statistical analyses using log-additive model has revealed that only IL-8 (rs4073) showed 
significant difference in genotype frequency between the control group and APN, ALN or 
combined cases (Table 7.1) for APN vs. control; ALN vs. control and combined vs. control, 
respectively). In addition, the genotype AA in IL-8 (rs4073) was associated with the severe 
upper UTIs (i.e. APN and ALN) in comparison to the TT and TA genotypes (Table 7.1) for 
APN vs. control; ALN vs. control and combined vs. control, respectively). The allele 
frequency analyses have shown that the minor allele, “A”, in IL-8 (rs4073) is more prevalent 
in the severe upper UTI groups than in the control for APN vs. control; ALN vs. control and 
combined vs. control, respectively (Table 7.2) (Cheng et al. 2011a). 
Since vesicoureteral reflux (VUR) has been suggested as the significant host risk factor for 
upper UTIs (Orellana et al. 2004; Artifoni et al. 2007), we subsequently evaluated the results 
of genetic analysis in the subgroup of APN and ALN patients with no VUR. In the no-VUR 
subgroup of APN and ALN patients, only ALN and APN+ALN group presented a 
statistically significant difference in IL-8 (rs4073) genotype frequency using log-additive 
model (OR (95% CI): 1.47 (1.03, 2.10); 1.50 (1.09, 2.06) for ALN vs. control; and combined vs. 
control, respectively). In comparison to the TT and TA genotypes in IL-8 (rs4073) SNP, a 
significant higher AA genotype frequency was noted in the no-VUR subgroup of ALN and 
APN+ALN cases (recessive model, OR (95% CI): 2.31 (1.15, 4.65); 2.15 (1.13, 4.09) for ALN 
vs. control; and combined vs. control, respectively). These two no-VUR subgroups (i.e. ALN 
and APN+ALN) also presented a significant higher minor allele (i.e. “A” in IL-8 (rs4073)) 
frequency than in the control (OR (95%CI): 1.43 (1.02, 2.01); 1.45 (1.07, 1.96) for ALN vs. 
control and combined vs. control, respectively). 
This investigation (Cheng et al. 2011a) has indicated that APN and ALN patients have 
distinctive higher AA genotype frequency and A allele occurrence in IL-8 (rs 4073) as 
compared to the controls. In contrast, no differences in TLR-4 (rs10759932), CXCR1 
(rs16858808) and CXCR2 (rs4674258) were noted among the APN, ALN and control. The 
polymorphism for IL-8 (rs4073) occurs at -251A>T position in the 5’ promoter region of IL-8.  
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Table 7.1. Genotypic analysis of single nucleotide polymorphisms (SNPs) (Cheng et al., 
2011a). 
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Hence, current finding is in parallel to an earlier report in which A allele in -251A>T is 
significantly associated with the presence of dimercapto-succinic acid scan documented 
APN (Artifoni et al. 2007). This has been attributed to the association of A allele with an 
increase in IL-8 production (Hull et al. 2001; Artifoni et al. 2007). In addition, AA genotype 
has been linked to the increased level of fecal IL-8 and the occurrence of enteroaggregative 
E. coli-associated diarrhea (Jiang et al. 2003). Therefore, the IL-8 (rs4073) SNP for APN and 
ALN patients could be related to the up-regulated IL-8 expression that has subsequently 
resulted in severe clinical inflammatory responses noted clinically. Furthermore, after 
elimination of VUR, the well-known risk factor for severe UTIs, from analyses, only ALN 
patients presented SNP in IL-8 (rs4073) while APN did not. Since the inflammatory 
responses in ALN patients are more sever than in APN ones (e.g. higher CRP value and 
longer fever duration after antibiotic treatment), this finding further supports the role of 
polymorphism in IL-8 (rs4073, -251A>T) in IL-8 up-regulation. 
In summary, the SNP in the inflammatory chemokine IL-8, a higher frequency in AA 
genotype and A allele, is involved in the susceptibility and clinical responses in pediatric 
APN and ALN cases. In addition, after removing VUR, the significant risk factor for 
parenchymal infection, from statistical analysis, the IL-8 SNP is only noted in the no-VUR 
subgroup of clinically more severe ALN patients. This suggests IL-8 (rs4073) SNP is 
correlated to the clinical severity of parenchymal infection, likely due to the up-regulated IL-
8 expression by the AA genotype and A allele. 
 
SNP Minor allele frequencya (%)  
APN vs. 
Control 
 
ALN vs. 
Control 
 
Combined vs. 
Control 
 Control APN ALN Combinedb  
OR 
(95% CI) 
Pc  
OR 
(95% CI) 
Pc  
OR (95% 
CI) 
Pc 
CXCR1 
(rs16858808) 
1.80 2.21 3.31 2.87  
1.23 
(0.40, 
3.81) 
0.72  
1.87 
(0.74, 
4.70) 
0.18  
1.61 
(0.68, 
3.79) 
0.28 
CXCR2 
(rs4674258) 
33.03 33.63 30.12 31.54  
1.03 
(0.73, 
1.44) 
0.88  
0.87 
(0.64, 
1.19) 
0.39  
0.93 
(0.72, 
1.22) 
0.62 
IL-8  
(rs4073) 
32.65 40.71 41.27 41.04  
1.42 
(1.02, 
1.97) 
0.04  
1.45 
(1.08, 
1.95) 
0.01  
1.44 
(1.11, 
1.86) 
0.01 
TLR-4 
(rs10759932) 
26.82 23.87 26.67 25.54  
0.86 
(0.59, 
1.24) 
0.41  
0.99 
(0.72, 
1.37) 
0.96  
0.94 
(0.70, 
1.24) 
0.65 
a Minor allele: CXCR1, T; CXCR2, T; IL-8, A; TLR-4, C. 
b Combined: APN+ALN 
c The P values are shown in bold when P < 0.05. 
Table 7.2. Allele frequency analysis of single nucleotide polymorphisms (SNPs) by logistic 
regression model. (Cheng et al., 2011a). 
8. Conclusion 
A new imaging scheme that combines US and CT has been developed for effective ALN 
diagnosis. In this scheme, patients suspected of suffering from UTI [i.e. who had pyuria (> 5 
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WBCs/high-power field), fever without focus or any symptoms/signs related to UTI, such 
as knocking pain, dysuria and frequency] underwent renal US during the 1st-2nd day 
following their admission to hospital. The CT assessment followed immediately when the 
initial US findings met either one of these two criteria, evidence of: (1) unilateral or bilateral 
nephromegaly; and (2) a focal renal mass. For children who presented with borderline 
nephromegaly ultrasonographically, CT was performed when the patient remained febrile 
for 72 hours subsequent to antibiotic-treatment commencement. ALN diagnosis was made 
on the basis of positive CT findings. 
Further, with this scheme, we have identified that a three-week antimicrobial therapy 
protocol, rather than the two-week scheme commonly used for APN treatment, should 
constitute the treatment of choice for all radiographically documented ALN patients. As for 
the likelihood in scar formation following the severe parenchymal infections, we have 
confirmed that pediatric patients with ALN could have higher possibility for scar formation 
than with APN. 
Through the urovirulence factor analyses, we have noted that the papG class II gene (gene 
associated with P-fimbriae of uropathogenic E. coli) was the most strongly associated 
pathogenic determinant for the pediatric ALN patients who have no underlying diseases 
except VUR. But PFGE analysis indicated that no major genotype was associated with the 
disease category. Thus the major pathogenic determinants may not be unique to any specific 
genetic lineage. In addition, using the MDCK epithelial cells model, we have confirmed that 
the ability to adhere to and produce cytotoxicity against uroepithelial cells appears a 
prerequisite factor for E. coli to cause more severe bacterial kidney infection, such as ALN 
(Cheng et al., 2011b). Much more, we have confirmed that E. coli isolates from urosepsis 
patients carried more virulence factors as compared to those from patients with cystitis, 
APN and ALN. This implicated that the number of urovirulent genes found in pathogenic 
isolates may be correlated with the clinical severity noted in pediatric UTIs. 
For the host factors that could influence the patient’s susceptibility to the sever parenchymal 
infections, we have identified SNP in the inflammatory chemokine IL-8, a higher frequency 
in AA genotype and A allele, is involved in the susceptibility and clinical responses in 
pediatric APN and ALN cases. Further, among the patients without VUR, this IL-8 SNP is 
only noted in the ALN patients while not in the APN cases. This finding implicates that this 
IL-8 SNP could lead to a higher IL-8 secretion level after bacterial infection, and, 
subsequently, more severe inflammatory responses found in the ALN patients.  
Despite of abovementioned findings in the pediatric patients with ALN, we have not 
explored the host genetic factors for the ALN patient proned to have recurrent UTIs. These 
patients might have some genetic polymorphisms that increase patient’s susceptibility to 
UTIs. A detailed longitudinal clinical follow-up plan would be needed to further elucidate 
the likely polymorphisms in these recurrent-UTI-prone ALN patients. In addition, building 
a proper animal model for ALN study will be attempted in the future study. The IL-8 
expression level among the patients diagnosed as cystitis, APN and ALN will also be 
compared to each other. Since the ALN patients are also likely to have renal scarring 
according to our previous findings, genetic polymorphisms likely to reduce the renal scars 
will also be evaluated in the future studies. 
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